Argenx
ARGX
#558
Rank
โ‚ฌ30.88 B
Marketcap
506,37ย โ‚ฌ
Share price
-5.92%
Change (1 day)
37.73%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

P/S ratio for Argenx (ARGX)

P/S ratio as of April 2025 (TTM): 15.7

According to Argenx 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.25. At the end of 2024 the company had a P/S ratio of 17.1.

P/S ratio history for Argenx from 2022 to 2021

PS ratio at the end of each year

Year P/S ratio Change
202417.1-7.08%
202318.4-63.94%
202251.0-17.81%
202162.1
201978.5-34.79%
2018120201.66%
201739.9
201425.2